Descriptor English: | Fluorodeoxyglucose F18 | ||||||
Descriptor Spanish: |
Fluorodesoxiglucosa F18
| ||||||
Descriptor Portuguese: | Fluordesoxiglucose F18 | ||||||
Descriptor French: | Fluorodésoxyglucose F18 | ||||||
Entry term(s): |
18F Fluorodeoxyglucose 18F-FDG 18FDG 2 Fluoro 2 deoxy D glucose 2 Fluoro 2 deoxyglucose 2-Fluoro-2-deoxy-D-glucose 2-Fluoro-2-deoxyglucose F 18, Fludeoxyglucose F 18, Fluorodeoxyglucose F18, Fluorodeoxyglucose Fludeoxyglucose F 18 Fluorine 18 fluorodeoxyglucose Fluorine-18-fluorodeoxyglucose Fluorodeoxyglucose F 18 Fluorodeoxyglucose, 18F |
||||||
Tree number(s): |
D09.254.229.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D019788 | ||||||
Scope note: | The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162) |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Radiopharmaceuticals |
||||||
Registry Number: | 0Z5B2CJX4D | ||||||
Previous Indexing: |
Deoxyglucose/analogs & derivatives (1978-1997) |
||||||
Public MeSH Note: | 2005(1998); see FLUDEOXYGLUCOSE F 18 1998-2004; FLUDEOXYGLUCOSE F 18 was indexed under DEOXYGLUCOSE/analogs & derivatives 1978-1997 |
||||||
History Note: | 2005(1979) |
||||||
DeCS ID: | 33478 | ||||||
Unique ID: | D019788 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1998/01/01 | ||||||
Date of Entry: | 1997/06/20 | ||||||
Revision Date: | 2013/07/08 |
Fluorodeoxyglucose F18
- Preferred
2-Fluoro-2-deoxy-D-glucose
- Broader
Concept UI |
M0029360 |
Scope note | The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162) |
Preferred term | Fluorodeoxyglucose F18 |
Entry term(s) |
18F Fluorodeoxyglucose 18F-FDG 18FDG F 18, Fludeoxyglucose F 18, Fluorodeoxyglucose F18, Fluorodeoxyglucose Fludeoxyglucose F 18 Fluorine 18 fluorodeoxyglucose Fluorine-18-fluorodeoxyglucose Fluorodeoxyglucose F 18 Fluorodeoxyglucose, 18F |
Concept UI |
M0029361 |
Preferred term | 2-Fluoro-2-deoxy-D-glucose |
Entry term(s) |
2 Fluoro 2 deoxy D glucose 2 Fluoro 2 deoxyglucose 2-Fluoro-2-deoxyglucose |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey